Additionally, functional in vitro experiments demonstrate that IBSP promotes the growth and aggressiveness of CRC, and the underlying mechanism involves IBSP enhancing the aberrant activation of the oncogenic CRC FYN/β-catenin signaling pathway72. The gene discussed is IBSP; the disease is colorectal carcinoma.